SAN DIEGO & BEIJING–(BUSINESS WIRE)–$PT #ClassAction–Shareholder rights law firm Robbins LLP reminds investors it is investigating Pintec Technology Holdings Limited (NASDAQ: PT) for potential material misstatements and violations of federal securities laws pursuant to its October 2018 initial public offering (“IPO”). Pintec offered more than $3.7 million American Depository Shares at $11.88 per share and raised $40.7 million in gross proceeds. Pintec’s stock has precipitously declined and by August 5, 2019, shares of Pintec closed at only $3.40 per share.
On June 15, 2020, Pintec disclosed that it could not timely file its 2019 annual report, disclosing it had “erroneously recorded revenue earned from certain technical service fee on a net basis” for fiscal 2017 and 2018. Since the IPO, Pintec’s stock has traded as low as $0.92 per share, significantly below the $11.88 offering price.
If you purchased shares of Pintec stock in its October 2018 IPO at $11.88 per share, click here.
Pintec Technology Holdings Limited (PT) Shareholders Have Legal Options
Contact us to learn more:
Leo Kandinov
(800) 350-6003
LKandinov@robbinsllp.com
Shareholder Information Form
Want to be notified if a class action against Pintec settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Contacts
Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com
New slot tournament, Blackjack Quest and poker event here this month SYDNEY--(BUSINESS WIRE)--A new month…
AUBURN HILLS, Mich.--(BUSINESS WIRE)--#safety--Teijin Automotive Technologies held a ribbon cutting today to celebrate the opening…
VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…
DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…
Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…